Parabilis Medicines, Inc. Common Stock (PBLS) — Net Asset Quality Index
Parabilis Medicines, Inc. Common Stock (PBLS) has a Net Asset Quality Index of 63.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $384.17 Million minus total liabilities of $139.95 Million yields net assets of $244.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Parabilis Medicines, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Parabilis Medicines, Inc. Common Stock Net Asset Quality Index Over Time (2024–2025)
This chart shows how Parabilis Medicines, Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the index stands at 63.6%, representing net assets of $244.22 Million against total assets of $384.17 Million USD. Explore Parabilis Medicines, Inc. Common Stock operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Parabilis Medicines, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Parabilis Medicines, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Parabilis Medicines, Inc. Common Stock (PBLS) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -20.4% | $-16.52 Million | $80.82 Million | $97.34 Million | ▼ -58.3 pp |
| 2024 | 37.8% | $56.44 Million | $149.25 Million | $92.81 Million | — |